XORTX Therapeutics XRTX Ratios (2020-2026)

NASDAQ XRTX
$0.91 -0.08 (-7.89%)
As of: Oct 21, 2026 · 12:35 PM EDT
Reported Financials

XORTX Therapeutics Quarterly Ratios

Periods 24 quarters
Latest Jun 2026

XORTX Therapeutics ratios data for the quarter ended Jun 2026. These financial ratios cover 24 quarters of results from Sep 2020 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

RatiosRatios Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Profitability
EBT Margin
-73.97%-74.45%-104.50%74.81%
EBIT Margin
-76.67%-74.45%-74.59%73.45%
EBITDA Margin
-70.25%-72.55%-73.36%76.60%
Operating Margin
-74.45%-74.59%73.45%
Net Margin
-73.97%-74.45%-71.03%74.81%
FCF Margin
0.15%0.10%-0.32%
Efficiency
Assets AverageAssets Avg.
11.72M16.03M13.61M11.70M11.65M11.01M8.73M7.22M6.05M5.76M5.42M4.32M3.97M3.80M3.12M2.78M2.75M2.41M4.16M
Equity AverageEquity Avg.
-2.42M-0.80M11.93M10.12M8.67M7.41M8.02M8.23M6.74M5.36M-8.12M-9.08M2.42M2.74M3.04M2.39M2.00M2.03M1.68M3.39M
Invested CapitalInvested Cap.
9.57M7.89M7.05M9.12M4.63M2.73M1.91M2.05M1.27M
Asset Utilization RatioAsset Util.
1.25
Leverage & Solvency
Interest Coverage RatioInterest Cover
-0.01M0.01M-636.40-105.31-34.76-41.02-28.42-23.08-20.9654.18-33.454.73-20.234.84-37.93-71.20-98.460.00M-502.55-628.43
Debt Ratio
0.010.010.010.010.000.00-0.02-0.01-0.01
Times Interest Earned
-0.01M0.01M-636.40-105.31-34.76-41.02-28.42-23.08-20.9654.18-33.454.73-20.234.84-37.93-71.20-98.460.00M-502.55-628.43
Valuation
Price to EarningsP/E
68.21
Price to SalesP/S
0.61
Price to BookP/B
18.2521.2317.3418.0715.656.9411.8713.340.991.401.541.281.331.691.551.882.220.55
Enterprise Value
293.86M224.87M215.54M154.42M132.56M98.88M54.99M81.63M76.10M1.17M3.56M0.72M0.98M1.81M1.74M2.37M1.87M3.05M2.60M2.03M
EV to EBIT
79.177.111.92
EV to EBITDA
76.261.971.25
Market Capitalization
297.78M239.66M227.97M164.84M141.46M109.30M62.90M87.80M81.16M4.62M7.40M3.80M3.28M4.28M3.64M3.43M3.07M3.91M2.85M3.02M
Return Ratios
Return on Sales [ROS]ROS
-76.67%-74.45%-74.59%73.45%
Return on Capital Employed [ROCE]ROCE
-2.63%-55.97%-62.84%-79.22%-29.10%-24.52%
Return on Assets [ROA]ROA
-11.59%-19.11%-40.40%-0.52%-84.58%-75.05%-83.62%-102.99%-46.88%-36.37%-34.96%-33.24%-103.67%-105.18%-108.62%-67.18%-22.33%47.99%8.59%
Return on Equity [ROE]ROE
-25.67%-54.35%-0.70%-133.03%-103.00%-88.72%-110.30%-52.91%-59.43%-150.58%-131.40%-142.06%-93.16%-30.23%68.79%10.54%

XORTX Therapeutics Ratios API

Pull XORTX Therapeutics's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=XRTX&statement=Ratios&frequency=Quarter&period=all&api_key=YOUR_API_KEY